8-K 1 utahmed8-k070105.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 1, 2005 Commission File No. 0-11178 ------- UTAH MEDICAL PRODUCTS, INC. --------------------------- (Exact name of Registrant as specified in its charter) UTAH 87-0342734 ------------------------------- ------------------ (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 7043 South 300 West Midvale, Utah 84047 ------------------- Address of principal executive offices Registrant's telephone number: (801) 566-1200 -------------- -------------------------------------------------------------------------------- ITEM 8.01 OTHER EVENTS -------------------------------------------------------------------------------- On July 1, 2005, Utah Medical Products, Inc. issued a press release providing an update on the status of FDA litigation. A copy of the press release is attached hereto as Exhibit 99.1 -------------------------------------------------------------------------------- SIGNATURES -------------------------------------------------------------------------------- Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. UTAH MEDICAL PRODUCTS, INC. REGISTRANT Date: 7/1/05 By: /s/ Kevin L. Cornwell -------------------- ----------------------- Kevin L. Cornwell CEO -------------------------------------------------------------------------------- EXHIBIT INDEX Index Number Description ------ ----------- 99.1 Press release issued July 1, 2005: UTMD Updates Status of FDA Lawsuit